Bob Blackman MP: written questions
Bob Blackman MP: full overview
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
100 published records · newest first.
Written questions
Migraines: DrugsDepartment of Health and Social CareTabled 29 Jun 2026AnsweredUIN 13788More
Question: To ask the Secretary of State for Health and Social Care, what mechanism exists for psychiatric adverse drug reaction signals, including Yellow Card reports and Prevention of Future Deaths reports, to be considered in national migraine prescribing guidanc
Answer: The safety of medicines is closely monitored through the Medicines and Healthcare products Regulatory Agency’s (MHRA) pharmacovigilance system. Reports submitted through the Yellow Card Scheme are used by the MHRA to identify and investigate potential adv...
Answered 7 Jul 2026
Original Parliament recordNeurology: DrugsDepartment of Health and Social CareTabled 29 Jun 2026AnsweredUIN 13787More
Question: To ask the Secretary of State for Health and Social Care, whether NHS England's neurology service specifications require providers to include structured mental health and medication safety fields in headache referral, assessment and prescribing templates.
Answer: NHS England’s service specification for adult neurology sets out the overall standards and outcomes expected of providers. The specification makes clear that providers should deliver a holistic assessment and management approach for people with neurologic...
Answered 7 Jul 2026
Original Parliament recordNeurology: DrugsDepartment of Health and Social CareTabled 29 Jun 2026AnsweredUIN 13786More
Question: To ask the Secretary of State for Health and Social Care, whether the Care Quality Commission's assessment framework requires providers to evidence medicines safety checks for psychiatric history, psychotropic medication use and previous psychiatric adver
Answer: The Care Quality Commission’s (CQC) Single assessment framework includes a quality statement that requires service providers to ensure medicines and treatments are safe and meet people’s needs and preferences by enabling them to be involved in planning, i...
Answered 6 Jul 2026
Original Parliament recordDiethylstilbestrol: Health EducationDepartment of Health and Social CareTabled 25 Jun 2026AnsweredUIN 13121More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that Government policy and NHS guidance relating to diethylstilbestrol (DES) exposure are communicated to and accessible by all people exposed to DES i
Answer: I apologise unreservedly and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families. National Health Service records are held by individual NHS organisations and gener...
Answered 29 Jun 2026
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 25 Jun 2026AnsweredUIN 13120More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to issue guidance to NHS England on the provision of additional cervical and vaginal cancer surveillance for women exposed in utero to diethylstilbestrol (DES), beyond HPV primary
Answer: I apologise unreservedly and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families. National Health Service records are held by individual NHS organisations and gener...
Answered 29 Jun 2026
Original Parliament recordDiethylstilbestrol: Medical RecordsDepartment of Health and Social CareTabled 25 Jun 2026AnsweredUIN 13119More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that individuals known to have been exposed to diethylstilbestrol (DES) in utero have that exposure recorded on their own NHS medical records, rather t
Answer: I apologise unreservedly and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families. National Health Service records are held by individual NHS organisations and gener...
Answered 29 Jun 2026
Original Parliament recordGynaecologyDepartment of Health and Social CareTabled 8 Jun 2026AnsweredUIN 7408More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to publish annual progress reports on the implementation of the 2026 Renewed Women’s Health Strategy for England.
Answer: The Renewed Women’s Health Strategy, published on the 15 April 2026, sets out 117 actions across four core commitments: acting on women’s voices and choices; transforming National Health Service performance in services that matter most to women; supportin...
Answered 16 Jun 2026
Original Parliament recordGynaecology: DisadvantagedDepartment of Health and Social CareTabled 8 Jun 2026AnsweredUIN 7407More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to specialist women’s health services for women in deprived areas.
Answer: The Government is committed to building a fairer Britain, to ensure people can live well for longer. Our reimagined National Health Service will tackle inequalities in both access and outcomes, as well as give everyone, no matter who they are or where the...
Answered 16 Jun 2026
Original Parliament recordWomen's Health HubsDepartment of Health and Social CareTabled 8 Jun 2026AnsweredUIN 7406More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of women’s health hubs on delivering the objectives of the 2026 Renewed Women’s Health Strategy for England.
Answer: The Renewed Women’s Health Strategy sets out a bold, long‑term plan to transform how the health and care system listens to, supports, and delivers for women and girls. It puts women’s voices and choices at the centre of care, drives faster improvements in...
Answered 16 Jun 2026
Original Parliament recordGynaecology: Waiting ListsDepartment of Health and Social CareTabled 8 Jun 2026AnsweredUIN 7405More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the 2026 Renewed Women’s Health Strategy for England on waiting times for gynaecology services.
Answer: The Renewed Women’s Health Strategy puts the 10-Year Health Plan’s new care model into action to deliver faster, tangible improvements across four outcomes that matter most to women across England. Through the Renewed Strategy, we will support integrated ...
Answered 16 Jun 2026
Original Parliament recordGynaecologyDepartment of Health and Social CareTabled 8 Jun 2026AnsweredUIN 7404More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the number of consultant obstetricians and gynaecologists to support delivery of the 2026 Renewed Women’s Health Strategy for England.
Answer: The Renewed Women’s Health Strategy was published on 15 April 2026 and sets out a bold, long‑term plan to transform how the health and care system listens to, supports, and delivers for women and girls across all regions in England.It puts women’s voices ...
Answered 16 Jun 2026
Original Parliament recordPrescriptions: Fees and ChargesDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7126More
Question: To ask the Secretary of State for Health and Social Care, if he will commit to a review of the prescription charge exemption list to reflect the changing nature of many long-term conditions including cystic fibrosis.
Answer: The Government currently has no plans to review or amend the list of medical conditions that entitle someone to apply for a medical exemption certificate.
Answered 15 Jun 2026
Original Parliament recordCystic FibrosisDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7125More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of co-morbidities such as liver disease which affects one in five people with cystic fibrosis as we mark cystic fibrosis awareness week from 8-14 June.
Answer: National Institute for Health and Care Excellence (NICE) guidelines recommend that patients and/or the families of people with cystic fibrosis are provided with the relevant information and the opportunity for discussion with clinicians on topics that inc...
Answered 11 Jun 2026
Original Parliament recordAntimicrobial Resistance: Cystic FibrosisDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7124More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the threat of antimicrobial resistance for people with cystic fibrosis as we mark cystic fibrosis awareness week from 8-14 June.
Answer: The United Kingdom’s 2024 to 2029 antimicrobial resistance (AMR) national action plan (NAP), published in May 2024, recognises that AMR impacts people differently. People with cystic fibrosis are an increased risk of infection, including resistant infecti...
Answered 11 Jun 2026
Original Parliament recordNeurological Diseases: Climate ChangeDepartment of Health and Social CareTabled 5 Jun 2026AnsweredUIN 7119More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of global temperatures on the health of people with neurological conditions, including epilepsy; and what research his Department is funding into
Answer: The UK Health Security Agency (UKHSA) has assessed the health impacts of rising temperatures through its Climate Change and Mental Health thematic assessment and the Adverse Weather and Health Plan Supporting Evidence 2024. These identify that people with...
Answered 15 Jun 2026
Original Parliament recordPatient Choice SchemesDepartment of Health and Social CareTabled 15 May 2026AnsweredUIN 1665More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the answer of 29 April to Question 129461, if he will outline (a) on what basis areas will be determined as having the highest health need; (b) a timeline for when the Choice Charter wi
Answer: The Government is committed to giving patients greater choice and control over their care. Patients have a legal right to choose where they go for their first appointment, when referred to consultant-led care as an outpatient.The 10-Year Health Plan commi...
Answered 1 Jun 2026
Original Parliament recordPatient Choice Schemes: Harrow EastDepartment of Health and Social CareTabled 23 Apr 2026AnsweredUIN 129463More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of ensuring a choice of NHS provider is offered upon referral on patients in Harrow East constituency.
Answer: Patients have a legal right to choose where they go for their first appointment when referred to consultant-led care as an outpatient. The NHS Constitution for England and the NHS Standing Rules Regulations set out patients' legal rights to make choices a...
Answered 29 Apr 2026
Original Parliament recordPatient Choice SchemesDepartment of Health and Social CareTabled 23 Apr 2026AnsweredUIN 129462More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that the merger of NHS England with his Department does not affect patients' right to choose healthcare providers.
Answer: Patients have a legal right to choose where they go for their first appointment when referred to consultant-led care as an outpatient. The NHS Constitution for England sets out patients' legal rights to make choices about their healthcare and the merger o...
Answered 29 Apr 2026
Original Parliament recordPatient Choice SchemesDepartment of Health and Social CareTabled 23 Apr 2026AnsweredUIN 129461More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the proportion of patients being offered a choice of providers upon referral.
Answer: Patients have a legal right to choose where they go for their first appointment when referred to consultant-led care as an outpatient. The NHS Constitution for England and the NHS Standing Rules Regulations set out patients' legal rights to make choices a...
Answered 29 Apr 2026
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 20 Apr 2026WithdrawnUIN 128226More
Question: To ask the Secretary of State for Health and Social Care, whether community pharmacy will play a role in CVD prevention and case finding as part of the Cardiovascular Disease Modern Framework.
Answer: No published answer in this record yet.
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 20 Apr 2026WithdrawnUIN 128225More
Question: To ask the Secretary of State for Health and Social Care, whether any community pharmacists assisted his Department in co-producing the Cardiovascular Disease Modern Framework.
Answer: No published answer in this record yet.
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 20 Apr 2026WithdrawnUIN 128224More
Question: To ask the Secretary of State for Health and Social Care, whether community pharmacists were consulted prior to the publication of the Cardiovascular Disease Modern Framework Service.
Answer: No published answer in this record yet.
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 20 Apr 2026WithdrawnUIN 128223More
Question: To ask the Secretary of State for Health and Social Care, if his Department will commission a funded community pharmacy lipid service pathway.
Answer: No published answer in this record yet.
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 15 Apr 2026AnsweredUIN 127426More
Question: To ask the Secretary of State for Health and Social Care, if community pharmacy will play a role in cardiovascular disease prevention and case finding as part of the upcoming Cardiovascular Disease Modern Framework.
Answer: Community pharmacy already plays an important role in cardiovascular disease (CVD) prevention through the hypertension case finding service which offers free, walk-in blood pressure checks to over 40 year olds. Since October 2021, 40 pharmacies have deliv...
Answered 22 Apr 2026
Original Parliament recordCardiovascular Diseases: Health ServicesDepartment of Health and Social CareTabled 15 Apr 2026AnsweredUIN 127425More
Question: To ask the Secretary of State for Health and Social Care, if any community pharmacists assisted his Department in co-producing the upcoming Cardiovascular Disease Modern Framework.
Answer: Community pharmacy already plays an important role in cardiovascular disease (CVD) prevention through the hypertension case finding service which offers free, walk-in blood pressure checks to over 40 year olds. Since October 2021, 40 pharmacies have deliv...
Answered 22 Apr 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →